Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JACC Case Rep ; 29(14): 102410, 2024 Jul 17.
Article in English | MEDLINE | ID: mdl-39006409

ABSTRACT

We report a case of infective endocarditis with a septal abscess that was complicated with abnormal blood flow from the left ventricle to the right atrium (Gerbode defect) along with abnormal blood flow from the aorta to the right atrium (atrial-aortic fistula). This is the first reported case of successful correction of both defects by a percutaneous approach.

2.
J Invasive Cardiol ; 25(4): E81-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23549503

ABSTRACT

BACKGROUND: Von Willebrand disease (vWD) results from quantitative or qualitative deficiency of von Willebrand factor (vWF). The occurrence of myocardial infarction is very rare in patients with vWD. A few case reports of acute coronary syndrome (ACS) in vWD patients are present in the literature, but no definite management recommendations are available for such patients. CASE REPORT: We report a case of successful percutaneous coronary intervention (PCI) with bare-metal stent (BMS) implantation in a 46-year-old woman with type 1 vWD and history of coronary artery disease (CAD). She received periprocedural dual-antiplatelet therapy for 2 weeks and then continued aspirin without any bleeding complications. MANAGEMENT PROPOSAL: The optimal management of patients with vWD and ACS is complex and presents a therapeutic challenge. We propose that dual-antiplatelet therapy can be used safely in most vWD patients presenting with ACS as most of them are type 1 vWD. PCI with BMS can be done safely. Long-term management of these patients requires a systemic approach including hematological consultation, ascertaining vWF levels, as well as patient education and close outpatient follow-up.


Subject(s)
Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/therapy , Disease Management , Percutaneous Coronary Intervention/methods , von Willebrand Diseases/epidemiology , Comorbidity , Drug Therapy, Combination , Female , Fibrinolytic Agents/therapeutic use , Humans , Middle Aged , Patient Education as Topic , Platelet Aggregation Inhibitors/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...